Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252681 · ClinicalTrials.gov registry record · NA
Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants
A NA study of Necrotizing Enterocolitis, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT00252681 is a NA study of Necrotizing Enterocolitis that has completed, run by Yale University. The registered enrollment target is 130 participants, below the 304-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00252681, a NA study of Necrotizing Enterocolitis, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to compare two surgical treatments for perforated necrotizing enterocolitis in very low birth weight babies.
Conditions Studied
Interventions
- PROCEDURE laparotomy
- PROCEDURE primary peritoneal drainage
Study Locations (1)
Connecticut
- Yale University School of Medicine Section of Pediatric Surgery - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 1999-07 |
| Est. Completion | 2005-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00252681
The ClinicalTrials.gov registry entry for NCT00252681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (57% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Necrotizing Enterocolitis appearing as the primary indexed condition, and to 2 interventions - of which laparotomy is the first listed.
NCT00252681 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00252681 about?
NCT00252681 is a clinical study titled "Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants". The primary purpose of this study is to compare two surgical treatments for perforated necrotizing enterocolitis in very low birth weight babies.
What is the current status of trial NCT00252681?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 1999-07. Estimated completion is 2005-06.
What conditions does trial NCT00252681 study?
This clinical trial studies the following conditions: Necrotizing Enterocolitis.
What interventions are being tested in trial NCT00252681?
The interventions under investigation include: laparotomy (PROCEDURE), primary peritoneal drainage (PROCEDURE).
Who is sponsoring clinical trial NCT00252681?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00252681 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Necrotizing Enterocolitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
RECRUITING · NA
-
Collaborative Research Group for Necrotizing Enterocolitis
COMPLETED · NA
-
Early Predictors of Necrotizing Enterocolitis in Neonates
RECRUITING
-
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
RECRUITING · Phase 1
-
A Cohort Study of the Intestinal Microbiota of Premature Infants
ACTIVE NOT RECRUITING
-
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.